Urologist-turned-founder Dr. Adam Kadlec shares how he built Rivermark and FloStent — a reversible, workflow-friendly device for BPH — by designing for real practice patterns and uncovering what drives trial enrollment.

Andrew Holman, MD, spent a decade building the immuno-autonomics concept before launching Inmedix's CloudHRV — a diagnostic that measures biological stress as a vital sign. His approach offers lessons in creating demand first.

May Health CEO Colby Holtshouse is tackling PCOS and infertility with a minimally invasive ovarian ablation device. She explains why staged evidence — built in layers rather than a massive trial — is the fastest path to early commercial traction.

Reia CEO Kaitlin Maier turned a student project into the first self-managed pessary that treats all stages of pelvic organ prolapse — proving that limited resources can sharpen design, focus, and innovation.